Copper supplementation has no effect on markers of DNA damage and liver function in healthy adults (FOODCUE project)

JM O'Connor, MP Bonham, E Turley, A McKeown, VJ McKelvey-Martin, WS Gilmore, JJ Strain

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background/Aims: Copper is routinely used in the laboratory to promote oxidation in vitro. However, copper concentrations are million-fold higher than physiological concentrations and, in contrast, accumulating evidence suggests that copper may have an antioxidant role in vivo. The aim of this study was to provide data on how increased intake of copper affected mononuclear leukocyte DNA damage and liver function in healthy young free-living men and women. Methods: The study design was a double-blind repeated crossover trial with treatment and intervening placebo periods, each of 6 weeks' duration. The following supplementations were given orally in sequence: CuSO4 at a dose of 3 mg copper/day and copper amino acid chelates at doses of 3 and 6 mg copper/day. Oxidative DNA damage was assessed using a modification of the alkaline Comet assay incorporating an endonuclease III digestion step. The assessment of liver function was by measurement of the liver enzymes, alanine aminotransferase and L-gamma-glutamyltransferase. Results: There was no significant alteration in mononuclear leukocyte DNA damage or on liver function after 6 weeks of copper supplementation at two doses (3 and 6 mg/day). Conclusions: Copper supplementation (giving total copper intake at the highest level of 7 mg/day) did not induce DNA damage or adversely affect liver function in healthy adults. Copyright (C) 2003 S. Karger AG, Basel.
LanguageEnglish
Pages201-206
JournalAnnals of Nutrition and Metabolism
Volume47
Issue number5
DOIs
Publication statusPublished - Sep 2003

Fingerprint

DNA Damage
Copper
Liver
Mononuclear Leukocytes
Comet Assay
gamma-Glutamyltransferase
Endonucleases
Alanine Transaminase
Cross-Over Studies
Digestion
Antioxidants
Placebos
Amino Acids
Enzymes

Cite this

O'Connor, JM ; Bonham, MP ; Turley, E ; McKeown, A ; McKelvey-Martin, VJ ; Gilmore, WS ; Strain, JJ. / Copper supplementation has no effect on markers of DNA damage and liver function in healthy adults (FOODCUE project). In: Annals of Nutrition and Metabolism. 2003 ; Vol. 47, No. 5. pp. 201-206.
@article{612e0d6808854de38821e6f763031feb,
title = "Copper supplementation has no effect on markers of DNA damage and liver function in healthy adults (FOODCUE project)",
abstract = "Background/Aims: Copper is routinely used in the laboratory to promote oxidation in vitro. However, copper concentrations are million-fold higher than physiological concentrations and, in contrast, accumulating evidence suggests that copper may have an antioxidant role in vivo. The aim of this study was to provide data on how increased intake of copper affected mononuclear leukocyte DNA damage and liver function in healthy young free-living men and women. Methods: The study design was a double-blind repeated crossover trial with treatment and intervening placebo periods, each of 6 weeks' duration. The following supplementations were given orally in sequence: CuSO4 at a dose of 3 mg copper/day and copper amino acid chelates at doses of 3 and 6 mg copper/day. Oxidative DNA damage was assessed using a modification of the alkaline Comet assay incorporating an endonuclease III digestion step. The assessment of liver function was by measurement of the liver enzymes, alanine aminotransferase and L-gamma-glutamyltransferase. Results: There was no significant alteration in mononuclear leukocyte DNA damage or on liver function after 6 weeks of copper supplementation at two doses (3 and 6 mg/day). Conclusions: Copper supplementation (giving total copper intake at the highest level of 7 mg/day) did not induce DNA damage or adversely affect liver function in healthy adults. Copyright (C) 2003 S. Karger AG, Basel.",
author = "JM O'Connor and MP Bonham and E Turley and A McKeown and VJ McKelvey-Martin and WS Gilmore and JJ Strain",
year = "2003",
month = "9",
doi = "10.1159/000070486",
language = "English",
volume = "47",
pages = "201--206",
journal = "Annals of Nutrition and Metabolism",
issn = "0250-6807",
number = "5",

}

Copper supplementation has no effect on markers of DNA damage and liver function in healthy adults (FOODCUE project). / O'Connor, JM; Bonham, MP; Turley, E; McKeown, A; McKelvey-Martin, VJ; Gilmore, WS; Strain, JJ.

In: Annals of Nutrition and Metabolism, Vol. 47, No. 5, 09.2003, p. 201-206.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Copper supplementation has no effect on markers of DNA damage and liver function in healthy adults (FOODCUE project)

AU - O'Connor, JM

AU - Bonham, MP

AU - Turley, E

AU - McKeown, A

AU - McKelvey-Martin, VJ

AU - Gilmore, WS

AU - Strain, JJ

PY - 2003/9

Y1 - 2003/9

N2 - Background/Aims: Copper is routinely used in the laboratory to promote oxidation in vitro. However, copper concentrations are million-fold higher than physiological concentrations and, in contrast, accumulating evidence suggests that copper may have an antioxidant role in vivo. The aim of this study was to provide data on how increased intake of copper affected mononuclear leukocyte DNA damage and liver function in healthy young free-living men and women. Methods: The study design was a double-blind repeated crossover trial with treatment and intervening placebo periods, each of 6 weeks' duration. The following supplementations were given orally in sequence: CuSO4 at a dose of 3 mg copper/day and copper amino acid chelates at doses of 3 and 6 mg copper/day. Oxidative DNA damage was assessed using a modification of the alkaline Comet assay incorporating an endonuclease III digestion step. The assessment of liver function was by measurement of the liver enzymes, alanine aminotransferase and L-gamma-glutamyltransferase. Results: There was no significant alteration in mononuclear leukocyte DNA damage or on liver function after 6 weeks of copper supplementation at two doses (3 and 6 mg/day). Conclusions: Copper supplementation (giving total copper intake at the highest level of 7 mg/day) did not induce DNA damage or adversely affect liver function in healthy adults. Copyright (C) 2003 S. Karger AG, Basel.

AB - Background/Aims: Copper is routinely used in the laboratory to promote oxidation in vitro. However, copper concentrations are million-fold higher than physiological concentrations and, in contrast, accumulating evidence suggests that copper may have an antioxidant role in vivo. The aim of this study was to provide data on how increased intake of copper affected mononuclear leukocyte DNA damage and liver function in healthy young free-living men and women. Methods: The study design was a double-blind repeated crossover trial with treatment and intervening placebo periods, each of 6 weeks' duration. The following supplementations were given orally in sequence: CuSO4 at a dose of 3 mg copper/day and copper amino acid chelates at doses of 3 and 6 mg copper/day. Oxidative DNA damage was assessed using a modification of the alkaline Comet assay incorporating an endonuclease III digestion step. The assessment of liver function was by measurement of the liver enzymes, alanine aminotransferase and L-gamma-glutamyltransferase. Results: There was no significant alteration in mononuclear leukocyte DNA damage or on liver function after 6 weeks of copper supplementation at two doses (3 and 6 mg/day). Conclusions: Copper supplementation (giving total copper intake at the highest level of 7 mg/day) did not induce DNA damage or adversely affect liver function in healthy adults. Copyright (C) 2003 S. Karger AG, Basel.

U2 - 10.1159/000070486

DO - 10.1159/000070486

M3 - Article

VL - 47

SP - 201

EP - 206

JO - Annals of Nutrition and Metabolism

T2 - Annals of Nutrition and Metabolism

JF - Annals of Nutrition and Metabolism

SN - 0250-6807

IS - 5

ER -